| ALK | Anaplastic lymphoma kinase |
| BOR | Best Overall Response |
| cfDNA | cell-free tumor DNA |
| CL | Confidence Limits |
| CT | Cycle Threshold |
| CTCs | Circulating Tumor Cells |
| CT-scan | Computed Tomography |
| ECOG PS | Eastern Cooperative Oncology Group Performance Status |
| EDTA | Ethylenediamine tetraacetic acid |
| EGFR | Epidermal growth factor receptor |
| EpCAM | Epithelial Cell Adhesion Molecule |
| GM | Geometrical Mean |
| H&E | Haematoxylin-Eosin |
| HR | Hazard Ratio |
| hTERT | human Telomerase Reverse Transcriptase |
| NSCLC | Non-small cell lung cancer |
| OS | Overall Survival |
| PD | Progressive Disease |
| PFS | Progression-Free Survival |
| PR | Partial Response |
| qPCR | quantitative PCR |
| RECIST | Response Evaluation Criteria in Solid Tumors |
| SD | Stable Disease |